• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19: the new challenge for rheumatologists. First update.

作者信息

Ferro Francesco, Elefante Elena, Puxeddu Ilaria, Baldini Chiara, Bartoloni Elena, Baratè Claudia, Galimberti Sara, Talarico Rosaria, Mosca Marta, Bombardieri Stefano

机构信息

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

出版信息

Clin Exp Rheumatol. 2020 May-Jun;38(3):373-382. doi: 10.55563/clinexprheumatol/yvn0nh. Epub 2020 May 26.

DOI:10.55563/clinexprheumatol/yvn0nh
PMID:32452355
Abstract
摘要

相似文献

1
COVID-19: the new challenge for rheumatologists. First update.新型冠状病毒肺炎：风湿病学家面临的新挑战。首次更新。
Clin Exp Rheumatol. 2020 May-Jun;38(3):373-382. doi: 10.55563/clinexprheumatol/yvn0nh. Epub 2020 May 26.
2
Lessons from the Italian COVID-19 frontline.来自意大利新冠疫情前线的经验教训。
Minerva Med. 2020 Aug;111(4):303-305. doi: 10.23736/S0026-4806.20.06664-1.
3
Trained innate immunity, COVID-19 therapeutic dilemma, and fake science.训练有素的固有免疫、新冠治疗困境与伪科学
Clinics (Sao Paulo). 2020;75:e2124. doi: 10.6061/clinics/2020/e2124. Epub 2020 Jul 10.
4
Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.2019年冠状病毒病（COVID-19）与抗风湿药物
Rheumatol Int. 2020 May;40(5):825-826. doi: 10.1007/s00296-020-04570-z. Epub 2020 Mar 30.
5
How and why are rheumatologists relevant to COVID-19?风湿病学家与新冠病毒疾病有怎样的关联，原因又是什么？
Joint Bone Spine. 2020 Jul;87(4):279-280. doi: 10.1016/j.jbspin.2020.04.006. Epub 2020 Apr 30.
6
Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?COVID-19 时代的风湿病学家：风湿病学家在风湿性疾病患者护理中会有新角色吗？
Clin Rheumatol. 2020 Nov;39(11):3177-3183. doi: 10.1007/s10067-020-05380-1. Epub 2020 Sep 5.
7
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.在大流行期间启动的 2019 年冠状病毒病随机临床试验的多发性特征。
JAMA Netw Open. 2020 Jul 1;3(7):e2015100. doi: 10.1001/jamanetworkopen.2020.15100.
8
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.一名使用司库奇尤单抗治疗的银屑病患者发生的复杂型2019冠状病毒病（COVID-19）
Int J Dermatol. 2020 Aug;59(8):e267-e268. doi: 10.1111/ijd.15008. Epub 2020 Jun 18.
9
Rheumatology in a time of Coronavirus: lessons from our early experiences.新冠疫情下的风湿病学：我们早期经验的教训
QJM. 2020 Oct 1;113(10):715-716. doi: 10.1093/qjmed/hcaa163.
10
Treatment of COVID-19: old tricks for new challenges.2019冠状病毒病的治疗：应对新挑战的老办法
Crit Care. 2020 Mar 16;24(1):91. doi: 10.1186/s13054-020-2818-6.

引用本文的文献

1
Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit.巴瑞替尼联合脉冲激素治疗 COVID-19 超高炎症反应：重症监护室中的风湿学治疗方法。
Int J Mol Sci. 2024 Jul 2;25(13):7273. doi: 10.3390/ijms25137273.
2
The Outcome of COVID-19 in Patients with a History of Taking Rituximab: A Narrative Review.接受利妥昔单抗治疗的患者感染 COVID-19 的结局：一项叙述性综述。
Iran J Med Sci. 2021 Nov;46(6):411-419. doi: 10.30476/IJMS.2021.88717.1946.
3
Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.
风湿病学大学教师对冠状病毒病-19（COVID-19）疫苗的看法：来自埃及的 vaXurvey 研究。
Rheumatol Int. 2021 Sep;41(9):1607-1616. doi: 10.1007/s00296-021-04941-0. Epub 2021 Jul 9.
4
The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients.150例系统性硬化症患者的COVID-19临床病程报告
Intern Emerg Med. 2021 Oct;16(7):2001-2003. doi: 10.1007/s11739-021-02727-7. Epub 2021 Apr 16.
5
Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists.儿科 COVID-19 的治疗方法：儿科风湿病专家的在线调查。
Rheumatol Int. 2021 May;41(5):911-920. doi: 10.1007/s00296-021-04824-4. Epub 2021 Mar 8.
6
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience.新型冠状病毒肺炎疫情对原发性干燥综合征的影响：意大利的经验
Front Med (Lausanne). 2020 Dec 7;7:608728. doi: 10.3389/fmed.2020.608728. eCollection 2020.
7
TEN/SJS-like lupus erythematosus presentation complicated by COVID-19.伴有新型冠状病毒肺炎的中毒性表皮坏死松解症/重症多形红斑样红斑狼疮表现
Dermatol Ther. 2021 Jan;34(1):e14612. doi: 10.1111/dth.14612. Epub 2020 Dec 10.
8
Efficacy of human coronavirus immune convalescent plasma for the treatment of corona virus disease -19 disease in hospitalized children: A protocol for systematic review and meta analysis.人冠状病毒免疫康复期血浆治疗住院儿童冠状病毒病-19的疗效：系统评价和荟萃分析方案
Medicine (Baltimore). 2020 Nov 6;99(45):e22017. doi: 10.1097/MD.0000000000022017.
9
Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs.2019 年冠状病毒病在风湿患者中的流行情况及疾病修饰抗风湿药物的疗效评价。
Intern Emerg Med. 2021 Jun;16(4):919-923. doi: 10.1007/s11739-020-02535-5. Epub 2020 Oct 31.
10
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.酪氨酸激酶抑制剂对慢性髓性白血病患者具有抗病毒作用：一种支持其用于抗击SARS-CoV-2的可能模型。
Front Oncol. 2020 Sep 2;10:1428. doi: 10.3389/fonc.2020.01428. eCollection 2020.